 Differences access AZT symptomatic HIV-infected persons OBJECT socioeconomic factors symptomatic HIV-infected persons zidovudine AZT DESIGN Cross-sectional survey part Robert Wood Johnson Foundation AIDS Health Services Program SETTING Public hospital clinics community-based AIDS organizations American cities PATIENTS HIV-seropositive outpatients October May MAIN RESULTS Males likely AZT females odds confidence interval insurance likely AZT odds confidence interval likely AZT non-whites odds confidence interval Intravenous drug users likely AZT non-drug users odds confidence interval Persons episode Pneumocystis carinii pneumonia likely AZT persons AIDS Pneumocystis carinii pneumonia odds confidence interval CONCLUSION authors groups access AZT antiretroviral agent survival patients symptomatic HIV infection